We manage the entire value chain, from product sourcing and registration to distribution and active market development. By controlling every stage of the process, we operate transparently and lean. For you, as a retailer or supplier, this means a single point of contact and maximum control on the outcome.
We select products from a broad European network of manufacturers and wholesalers. Competitive purchasing based on quality, availability, and commercial opportunities, including EU parallel imported products at lower prices or better availability.
Our Quality and Regulatory Affairs team manages all required licences and national approvals. A product is only released to the market once it’s fully compliant.
In our own production facility, we ensure EU packaging complies with national regulations: replace translated leaflets and add mandatory labelling to prepare the packaging for the local market.
From our climate-controlled warehouse, we manage distribution to wholesalers, pharmacies, drugstores and webshops in the Netherlands and Belgium, in line with GDP guidelines.
Our team of account managers supports retailers with personal advice, promotions and campaigns for both physical stores and online channels.
Based on consumer purchasing behaviour and real-time market data, we advise retailers on optimizing the product mix for better shelf presentation and higher category revenue.
The prices and availability of medicines and healthcare products can vary significantly between national markets, even within a highly integrated region such as the European Union. These differences create a commercial opportunity to source registered EU medicines and approved EU healthcare products from lower-priced markets and supply them to markets where prices are higher. This process is known as parallel import.
A key characteristic of parallel import is that the medicines and healthcare products are manufactured by the original manufacturer but distributed through an independent distribution channel (a wholesaler), rather than through the manufacturer’s official distribution network.
Although the imported EU product is the same medicine or healthcare product, the distribution route differs. Parallel import is legally permitted within the European Union, based on the principle of exhaustion of intellectual property rights and the free movement of goods.
From manufacturer to consumer, every parallel-imported product goes through several stages:
Produces the original EU product
Purchasing and storage from the market
Sourcing, registration & national distribution
Adaptation to national regulations
Delivery to licensed outlets
Safe, affordable and fully approved product
Parallel-imported EU medicines must obtain a national licence and regulatory approval before they can be released and delivered on another national market.
In addition, parallel-imported EU medicines and healthcare products generally require packaging adjustments to comply with national regulations.
These adjustments include the following:
Our in-house Regulatory Affairs team manages the entire process, from application and repackaging to national distribution.
In our GMP-certified production facility, we carry out repackaging and relabelling work for OTC products.
